Breaking News Instant updates and real-time market news.

FB

Facebook

$163.87

-2.45 (-1.47%)

06:23
04/13/18
04/13
06:23
04/13/18
06:23

Facebook doesn't expect revenue impact over privacy concerns, WSJ reports

Facebook does not expect to see a significant sales impact from the uproar over its users' digital privacy following the company's Cambridge Analytica scandal, the Wall Street Journal reports, citing Facebook VP of global marketing solutions Carolyn Everson. The social media site, which also does not expect tougher privacy laws to cut into its ad sales, said users largely have not changed their privacy settings in the past four weeks amid heightened scrutiny over how it handles individual data. Reference Link

  • 17

    Apr

  • 25

    Apr

FB Facebook
$163.87

-2.45 (-1.47%)

04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
RHCO
04/11/18
NO CHANGE
Target $225
RHCO
Buy
Facebook CEO 'cooperative and well prepared' in Senate testimony, says SunTrust
SunTrust analyst Youssef Squali keeps his Buy rating and $225 price target on Facebook following the 4-hour testimony by CEO Mark Zuckerberg in front of the U.S. Senate yesterday. The analyst says Zuckerberg appeared "well-prepared and cooperative" in defending Facebook position while also acknowledging its mistakes and expressing willingness to implement major platform changes. Squali calls the testimony a "seminal event" that will likely lead to increased regulation, but also maintains the view that large advertising platforms like Facebook should remain favored by more government oversight. The analyst maintains his view of no evidence of flight by large digital advertisers and no indication that users are leaving Facebook en masse. Squali also keeps his positive view on the stock's compelling valuation.
04/11/18
ARGS
04/11/18
NO CHANGE
Target $214
ARGS
Buy
Facebook price target lowered to $214 from $237 at Argus
Argus analyst Joseph Bonner lowered his price target on Facebook to $214 and also reduced his FY18 EPS target to $8.54 from $8.61, saying the headline risk for the company has increased from the Cambridge Analytica scandal as well as the reported U.S. election tampering. Bonner contends that Facebook may be faced with "material" regulatory action and also may experience a decline in user engagement from the privacy related backlash. The analyst notes however that Facebook's operational results are strong, with earnings growth 65% and revenue growth of 47% last year, while its large daily active user base gives it the momentum to withstand the headwinds.
04/11/18
WELS
04/11/18
NO CHANGE
Target $230
WELS
Outperform
Facebook CEO exceeds expecations in congressional hearing, says Wells Fargo
Following the first day of Congressional testimony by CEO Mark Zuckerberg, Wells Fargo analyst Ken Sena says the executive exceeded investor expectations. "He appeared focused, conciliatory, and genuinely engaged in a productive discussion" with legislators on how best to rectify the company's loss in public trust and the company's roadmap to safeguard against future abuses, the analyst contends. Sena sees this as a positive sign for investors, even though another long day of testimony remains ahead. He reiterates an Outperform rating and $230 price target on the shares.

TODAY'S FREE FLY STORIES

IYR

DJ US Real Estate Index Fund

$81.37

-0.19 (-0.23%)

06:42
07/16/18
07/16
06:42
07/16/18
06:42
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$118.36

0.2 (0.17%)

06:42
07/16/18
07/16
06:42
07/16/18
06:42
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$21.90

0.15 (0.69%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAR

Saratoga Investment

$24.63

-0.08 (-0.32%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Upgrade
Saratoga Investment rating change  »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

EWH

MSCI Hong Kong Index

$24.46

0.07 (0.29%)

06:41
07/16/18
07/16
06:41
07/16/18
06:41
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNT

Innovate Biopharmaceuticals

$23.72

0.12 (0.51%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
Innovate Biopharmaceuticals management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EWG

iShares MSCI Germany

$30.64

0.095 (0.31%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPX

GP Strategies

$19.00

0.4 (2.15%)

06:40
07/16/18
07/16
06:40
07/16/18
06:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

IJR

iShares Core S&P Small Cap ETF

$85.89

-0.07 (-0.08%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$16.37

0.01 (0.06%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Sally Beauty rating change  »

Sally Beauty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

GLYC

GlycoMimetics

$17.12

0.32 (1.90%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Conference/Events
GlycoMimetics management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EEM

MSCI Emerging Markets Index

$43.86

0.06 (0.14%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAT

Waters

$198.07

-0.5 (-0.25%)

06:39
07/16/18
07/16
06:39
07/16/18
06:39
Downgrade
Waters rating change  »

Waters downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SAR

Saratoga Investment

$24.63

-0.08 (-0.32%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Downgrade
Saratoga Investment rating change  »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ENZ

Enzo Biochem

$5.13

-0.01 (-0.19%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Conference/Events
Enzo Biochem management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PJT

PJT Partners

$56.90

-0.08 (-0.14%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Downgrade
PJT Partners rating change  »

PJT Partners downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCEL

Vericel

$9.05

-1.05 (-10.40%)

06:38
07/16/18
07/16
06:38
07/16/18
06:38
Upgrade
Vericel rating change  »

Vericel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$50.24

-0.21 (-0.42%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$96.50

-0.87 (-0.89%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Downgrade
Hasbro rating change  »

Hasbro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XERS

Xeris Pharmaceuticals

$18.26

-0.18 (-0.98%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Initiation
Xeris Pharmaceuticals initiated  »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAE

CAE

$20.84

-0.15 (-0.71%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Conference/Events
CAE management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

UUP

PowerShares DB US Dollar Index Up

$25.01

-0.02 (-0.08%)

06:37
07/16/18
07/16
06:37
07/16/18
06:37
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$21.61

(0.00%)

06:36
07/16/18
07/16
06:36
07/16/18
06:36
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$129.54

2.18 (1.71%)

06:35
07/16/18
07/16
06:35
07/16/18
06:35
Hot Stocks
United Technologies consortium, Vietnam Airlines sign three-year agreement »

Vietnam Airlines has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

HPQ

HP Inc.

$23.71

0.18 (0.76%)

06:35
07/16/18
07/16
06:35
07/16/18
06:35
Recommendations
HP Inc. analyst commentary  »

HP has 'multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.